Meet the new 2022 Grant Recipients and learn more about their research projects
Dr Kate Vandyke
Is it possible to predict myeloma risk by looking at factors produced by ageing bone marrow cells?
Dr Camille Guillery
Can we prevent relapse in children with leukaemia by using natural cells found in umbilical cord blood?
Dr Rachel Thijssen
Understanding more about why people with chronic lymphocytic leukaemia can become resistant to treatment.
Learn more about PdCCRS Cancer Australia Grants
Previous recipients
Dr Hannah Wardill
Testing new ways to minimise or prevent the debilitating and potentially deadly graft vs host disease (GvHD) in children who undergo a stem cell transplant.
Dr Kyohei Nakamura
Working towards a new approach to improve the body’s immune response against B-cell lymphoma.
Dr Laurence Cheung
Studying the interaction between bone and leukaemia cells to improve treatment outcomes in childhood leukaemia
Dr Melissa Cantley
Developing new tests to identify which individuals with smouldering myeloma are at risk of developing myeloma
Dr Kate Vandyke
Increasing the efficiency while decreasing toxicity of myeloma therapies
Dr Laura Bray
Developing new models for drug testing to understand the biology and mechanisms of drug resistance in AML
Dr Michelle Henderson
Developing a new drug a as a novel therapeutic strategy for aggressive leukaemia in children
Dr Jenny Wang
Developing a new targeted therapy with minimal side effects and toxicity to improve the outcome of childhood AML
Dr Gabriela Brumatti
Using novel combination therapy to increase the changes of cure for childhood AML